1. Oncogenic ras represses transforming growth factor-beta /Smad signaling by degrading tumor suppressor Smad4. Saha D, Datta PK, Beauchamp RD (2001) J Biol Chem 276(31): 29531-7
    › Primary publication · 11371552 (PubMed)
  2. Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice. Deane NG, Parker MA, Aramandla R, Diehl L, Lee WJ, Washington MK, Nanney LB, Shyr Y, Beauchamp RD (2001) Cancer Res 61(14): 5389-95
    › Primary publication · 11454681 (PubMed)
  3. Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. Sheng H, Shao J, Dixon DA, Williams CS, Prescott SM, DuBois RN, Beauchamp RD (2000) J Biol Chem 275(9): 6628-35
    › Primary publication · 10692471 (PubMed)
  4. Posttranscriptional regulation of cyclooxygenase-2 in rat intestinal epithelial cells. Zhang Z, Sheng H, Shao J, Beauchamp RD, DuBois RN (2000) Neoplasia 2(6): 523-30
    › Primary publication · 11228545 (PubMed) · PMC1508084 (PubMed Central)
  5. Oncogenic Ras-mediated cell growth arrest and apoptosis are associated with increased ubiquitin-dependent cyclin D1 degradation. Shao J, Sheng H, DuBois RN, Beauchamp RD (2000) J Biol Chem 275(30): 22916-24
    › Primary publication · 10781597 (PubMed)
  6. NF-kappa B is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis. Jo H, Zhang R, Zhang H, McKinsey TA, Shao J, Beauchamp RD, Ballard DW, Liang P (2000) Oncogene 19(7): 841-9
    › Citation · 10702792 (PubMed)
  7. Inhibition of pRb phosphorylation and cell cycle progression by an antennapedia-p16(INK4A) fusion peptide in pancreatic cancer cells. Fujimoto K, Hosotani R, Miyamoto Y, Doi R, Koshiba T, Otaka A, Fujii N, Beauchamp RD, Imamura M (2000) Cancer Lett 159(2): 151-8
    › Citation · 10996726 (PubMed)
  8. Transformation of intestinal epithelial cells by chronic TGF-beta1 treatment results in downregulation of the type II TGF-beta receptor and induction of cyclooxygenase-2. Sheng H, Shao J, O'Mahony CA, Lamps L, Albo D, Isakson PC, Berger DH, DuBois RN, Beauchamp RD (1999) Oncogene 18(4): 855-67
    › Primary publication · 10023661 (PubMed)
  9. Synergistic induction of cyclooxygenase-2 by transforming growth factor-beta1 and epidermal growth factor inhibits apoptosis in epithelial cells. Saha D, Datta PK, Sheng H, Morrow JD, Wada M, Moses HL, Beauchamp RD (1999) Neoplasia 1(6): 508-17
    › Primary publication · 10935498 (PubMed) · PMC1508120 (PubMed Central)
  10. Coordinate regulation of cyclooxygenase-2 and TGF-beta1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors. Shao J, Sheng H, Aramandla R, Pereira MA, Lubet RA, Hawk E, Grogan L, Kirsch IR, Washington MK, Beauchamp RD, DuBois RN (1999) Carcinogenesis 20(2): 185-91
    › Primary publication · 10069452 (PubMed)